Edition:
India

Fujifilm Holdings Corp (4901.T)

4901.T on Tokyo Stock Exchange

5,362JPY
22 Oct 2020
Change (% chg)

¥7 (+0.13%)
Prev Close
¥5,355
Open
¥5,343
Day's High
¥5,391
Day's Low
¥5,313
Volume
1,311,700
Avg. Vol
1,840,179
52-wk High
¥6,420
52-wk Low
¥4,152

Select another date:
Photo

Fujifilm partners Shanghai firm to seek China COVID-19 approval for Avigan

TOKYO Japan's Fujifilm Holdings Corp said on Thursday it has partnered with Shanghai-based Carelink Pharmaceutical Co to seek approval in China for Avigan to treat COVID-19 and influenza.

Fujifilm partners Shanghai firm to seek China COVID-19 approval for Avigan

TOKYO Japan's Fujifilm Holdings Corp said on Thursday it has partnered with Shanghai-based Carelink Pharmaceutical Co to seek approval in China for Avigan to treat COVID-19 and influenza.

UPDATE 1-Fujifilm partners Shanghai firm to seek China COVID-19 approval for Avigan

TOKYO, Oct 22 Japan's Fujifilm Holdings Corp said on Thursday it has partnered with Shanghai-based Carelink Pharmaceutical Co to seek approval in China for Avigan to treat COVID-19 and influenza.

Fujifilm seeks approval for Avigan as COVID-19 treatment in Japan

TOKYO Fujifilm Holdings Corp said on Friday it was seeking approval for its flu drug Avigan as a treatment for COVID-19 in Japan, a move that comes after a late-stage study showed reduced recovery time for patients with non-severe symptoms.

Fujifilm seeks approval for Avigan as COVID-19 treatment in Japan

TOKYO Fujifilm Holdings Corp said on Friday it was seeking approval for its flu drug Avigan as a treatment for COVID-19 in Japan, a move that comes after a late-stage study showed reduced recovery time for patients with non-severe symptoms.

REFILE-UPDATE 3-Fujifilm seeks approval for Avigan as COVID-19 treatment in Japan

TOKYO, Oct 16 Fujifilm Holdings Corp said on Friday it was seeking approval for its flu drug Avigan as a treatment for COVID-19 in Japan, a move that comes after a late-stage study showed reduced recovery time for patients with non-severe symptoms.

Fujifilm seeks approval for Avigan as COVID-19 treatment in Japan

TOKYO Fujifilm Holdings Corp said on Friday it was seeking approval for its flu drug Avigan as a treatment for COVID-19 in Japan, a move that comes after a late-stage study showed reduced recovery time for patients with non-severe symptoms.

Fujifilm applies for approval of Avigan as COVID-19 treatment in Japan

TOKYO, Oct 16 Fujifilm Holdings Corp said on Friday it had applied for approval in Japan of its anti-influenza drug Avigan as a treatment for COVID-19.

UPDATE 3-Eli Lilly in deal to supply COVID-19 drugs to low-income countries

Oct 8 Eli Lilly and Co said on Thursday it had entered into an agreement with the Bill & Melinda Gates Foundation for potential supply of its experimental antibody treatments for COVID-19 to low and middle-income countries.

Fujifilm signs manufacturing contract with U.S. firm VLP for COVID-19 vaccine

TOKYO Fujifilm Holdings Corp said on Thursday that it had signed a manufacturing contract agreement with U.S.-based firm VLP Therapeutics for a COVID-19 vaccine formulation.

Select another date: